Top 8 Must-See AI News Updates Investors Probably Missed

6. Aclarion Inc. (NASDAQ:ACON)

Number of Hedge Fund Holders: 3

Aclarion Inc. (NASDAQ:ACON) is a healthcare technology firm that uses biomarkers and proprietary “augmented intelligence” algorithms within its “NOCISCAN” software application to help physicians identify the source of chronic low back pain by analyzing the chemical makeup of intervertebral discs in the spine, which enables them to offer targeted treatment plans.

On February 20th, Aclarion Inc. (NASDAQ:ACON) announced it will participate in the 2025 Spine Summit where renowned orthopedic surgeon Nicholas Theodore will discuss how NOCISCAN is transforming spine surgery by combining cutting-edge MR Spectroscopy with augmented intelligence.

“Disruptive technologies require strong advocacy from physician luminaries, and the insights provided by Dr. Theodore and the Aclarion KOL team have been valuable as we strive to make NOCISCAN more broadly available. We look forward to Dr. Theodore’s presentation at the Spine Summit as he highlights how NOCISCAN empowers physicians to ‘see’ painful discs that are invisible with traditional imaging so they can develop tailored treatment plans for patients with chronic low back pain,”

-said Brent Ness, CEO of Aclarion Inc.